Karen S. Wright

Karen S. Wright has extensive experience in finance and leadership roles. Karen S. started their career at Genentech, Inc. in 1984 as a Sr. Controller and later served as the Controller of Marketing and Sales. From 1997 to 2001, they worked at Elan Pharmaceuticals, Inc. as a Sr. Director of Finance. Karen S. then joined Cytokinetics, Inc. as the Sr. Director of Finance from 2001 to 2005. Karen continued to progress in their career and served as the VP Finance - Corporate Controller at Intermune, Inc. from 2004 to 2006. Karen S. then joined VIA Pharmaceuticals, Inc. in 2006 as a VP Finance, Corporate Controller and Principal Accounting Officer until 2011. From 2011 to 2014, Karen held the position of VP Finance, Corporate Controller at Veracyte, Inc. Before joining Jaguar Health, Inc. in 2015 as the CFO and Treasurer, they served as the Head of Finance at Clene Nanomedicine, Inc. for a year. Currently, Karen is working at Structure Therapeutics as the Senior Vice President of Finance, a position they have held since 2020.

Karen S. Wright has a Bachelor of Science degree in Accounting and Marketing from the University of California - Walter A. Haas School of Business. The years of their education are not specified.